BM Global News
  • Home
  • News
  • Politics
  • Business
  • Canada
  • Entertainment
  • Europe
  • Fashion and Lifestyle
  • Health
  • Sports
  • Technology
  • Travel
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Canada
  • Entertainment
  • Europe
  • Fashion and Lifestyle
  • Health
  • Sports
  • Technology
  • Travel
No Result
View All Result
BM Global News
No Result
View All Result
Home Middle East

EU antitrust enforcers team up with US and UK on pharmaceutical mergers

BM Global News Admin by BM Global News Admin
March 16, 2021
in Middle East
0
492
SHARES
1.4k
VIEWS
Share on FacebookShare on TwitterShare on EMail


EU antitrust enforcers have teamed up with their US and British counterparts to share expertise on how to examine mergers in the pharmaceutical industry amid concerns such deals could push up prices or hold back innovation.

The COVID-19 pandemic and vaccine supply bottlenecks have spurred regulatory interest in the pharmaceutical industry which has seen a wave of consolidation in recent years.

For more coronavirus news, visit our dedicated page.

The European Commission said the working group, which was launched on Tuesday, included the US Federal Trade Commission (FTC), the Canadian Competition Bureau, Britain’s Competition and Markets Authority and the US Department of Justice.

The group would “take stock of the lessons learned in recent years and explore new ways to foster vibrant competition to the benefit of citizens”, European Competition Commissioner Margrethe Vestager said in a statement.

The EU competition enforcer said greater scrutiny of pharmaceutical deals was needed to single out those that might lead to higher drug prices, lower innovation or anti-competitive conduct.

“Given the high volume of pharmaceutical mergers in recent years, amid skyrocketing drug prices and ongoing concerns about anti-competitive conduct in the industry, it is imperative that we rethink our approach toward pharmaceutical merger review,” FTC Acting Chair Rebecca Slaughter said in a statement.

High and rising US prescription drug prices, even for older medicines like insulin and epinephrine, have been a focus of concern for both US political parties. Both former President Donald Trump, in his 2016 campaign, and President Joe Biden, in his 2020 campaign, pledged to reduce drug costs.

Read more:

Saudi Arabia reports drop in cases, detects 403 COVID-19 infections

Greece says first migrant dies of COVID-19 since the pandemic

Positive COVID-19 test rates top 25 pct in some US Midwest states



Source link

Tags: antitrustArab NewsArabic NewsenforcersmergersMiddle East NewsNews Middle eastpharmaceuticalteam
BM Global News Admin

BM Global News Admin

Related Posts

Middle East

German Health Minister Spahn floats lifting of mask rules

June 14, 2021
Middle East

US condemns Houthi drone attack on school in Saudi Arabia

June 14, 2021
Middle East

Beats Studio Buds aim to deliver high-quality sound in a tiny package

June 14, 2021
  • Advertise
  • Contact us
  • Press Release
  • Privacy Policy

Copyright 2022 © BM Global News. Enjoy our Latest World News.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Canada
  • Entertainment
  • Europe
  • Fashion and Lifestyle
  • Health
  • Sports
  • Technology
  • Travel

Copyright 2022 © BM Global News. Enjoy our Latest World News.